Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1932 1
1943 1
1946 3
1947 6
1948 5
1949 2
1950 12
1951 19
1952 14
1953 23
1954 16
1955 23
1956 39
1957 23
1958 25
1959 42
1960 33
1961 41
1962 47
1963 55
1964 59
1965 77
1966 61
1967 81
1968 106
1969 63
1970 78
1971 97
1972 89
1973 103
1974 128
1975 95
1976 120
1977 104
1978 114
1979 157
1980 181
1981 176
1982 189
1983 190
1984 209
1985 223
1986 233
1987 221
1988 236
1989 277
1990 272
1991 312
1992 326
1993 242
1994 320
1995 325
1996 302
1997 306
1998 338
1999 350
2000 339
2001 363
2002 353
2003 389
2004 479
2005 472
2006 546
2007 533
2008 585
2009 610
2010 610
2011 669
2012 729
2013 785
2014 738
2015 745
2016 834
2017 779
2018 858
2019 795
2020 663
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

18,899 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Malignant Peritoneal Mesothelioma.
Levý M, Boublíková L, Büchler T, Šimša J. Levý M, et al. Klin Onkol. 2019 Fall;32(5):333-337. doi: 10.14735/amko2019333. Klin Onkol. 2019. PMID: 31610664 Review. English.
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleura of the thoracic cavity, followed by the peritoneum, pericardium, or tinea vaginalis testis. Malignant peritoneal mesothelioma (MPM) accounts for 10-15% of all mesotheliomas
Malignant mesothelioma is a highly malignant disease that most often occurs in the pleura of the thoracic cavity, followed by the per …
[Mesothelioma].
Tischoff I, Tannapfel A. Tischoff I, et al. Pathologe. 2017 Nov;38(6):547-560. doi: 10.1007/s00292-017-0364-z. Pathologe. 2017. PMID: 28986649 German.
In Germany, malignant mesotheliomas caused by occupational asbestos exposure are compensated as occupational disease since 1977. ...Especially, the pathohistological differentiation between atypical reactive mesothelial proliferation from malignant mesothelioma is a …
In Germany, malignant mesotheliomas caused by occupational asbestos exposure are compensated as occupational disease since 1977. ...E …
Malignant Mesothelioma Diagnosis.
Arif Q, Husain AN. Arif Q, et al. Arch Pathol Lab Med. 2015 Aug;139(8):978-80. doi: 10.5858/arpa.2013-0381-RA. Arch Pathol Lab Med. 2015. PMID: 26230591 Free article. Review.
CONTEXT: Malignant mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors including carcinomas and sarcomas. ...It is recommended that at least 2 mesothelial and 2 carcinoma markers with greater than 80% sensitivi …
CONTEXT: Malignant mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors …
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States.
Lemen RA. Lemen RA. J Toxicol Environ Health B Crit Rev. 2016;19(5-6):250-265. doi: 10.1080/10937404.2016.1195323. J Toxicol Environ Health B Crit Rev. 2016. PMID: 27705549
Mesothelioma, a rare tumor, is highly correlated with asbestos exposure. Mesothelioma, similar to all asbestos-related diseases, is dose/intensity dependent to some degree, and studies showed the risk of mesothelioma rises with cumulative exposures. ...It is
Mesothelioma, a rare tumor, is highly correlated with asbestos exposure. Mesothelioma, similar to all asbestos-related disease
The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment.
Galani V, Varouktsi A, Papadatos SS, Mitselou A, Sainis I, Constantopoulos S, Dalavanga Y. Galani V, et al. Cancer Chemother Pharmacol. 2019 Aug;84(2):241-253. doi: 10.1007/s00280-019-03878-3. Epub 2019 May 22. Cancer Chemother Pharmacol. 2019. PMID: 31119375 Review.
Malignant mesothelioma (MM) is a highly aggressive tumor that is strongly related to asbestos fiber exposure. The tumorigenesis procedure in MM is complex, and many pathogenetic mechanisms including chronic inflammation, deregulation of cell death, and the genomic copy-num …
Malignant mesothelioma (MM) is a highly aggressive tumor that is strongly related to asbestos fiber exposure. The tumorigenesis proce …
Recent Advances in the Diagnosis of Malignant Mesothelioma: Focus on Approach in Challenging Cases and in Limited Tissue and Cytologic Samples.
Monaco S, Mehrad M, Dacic S. Monaco S, et al. Adv Anat Pathol. 2018 Jan;25(1):24-30. doi: 10.1097/PAP.0000000000000180. Adv Anat Pathol. 2018. PMID: 29227332 Review.
A great morphologic challenge for pathologists is the separation of benign reactive mesothelial proliferations from malignant mesotheliomas. ...Recent advances in mesothelioma genetics resulted in identification of BAP1 mutations and p16 deletions as features of mal …
A great morphologic challenge for pathologists is the separation of benign reactive mesothelial proliferations from malignant mesotheliom
Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
Kawai T, Ogata S, Nakashima H, Urabe S, Murakami I, Hiroshima K. Kawai T, et al. Hum Pathol. 2019 Nov;93:23-29. doi: 10.1016/j.humpath.2019.08.016. Epub 2019 Aug 22. Hum Pathol. 2019. PMID: 31445842
Some mesothelioma cases, such as those of the deciduoid type, have also been reported to possess such rhabdoid features. Since this topic has not been studied in malignant mesothelioma, we analyzed the immunohistochemical expression of SMARCB1/INI1 in malignant m
Some mesothelioma cases, such as those of the deciduoid type, have also been reported to possess such rhabdoid features. Since this t …
Malignant mesothelioma.
Moore AJ, Parker RJ, Wiggins J. Moore AJ, et al. Orphanet J Rare Dis. 2008 Dec 19;3:34. doi: 10.1186/1750-1172-3-34. Orphanet J Rare Dis. 2008. PMID: 19099560 Free PMC article. Review.
The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers. Its incidence is increasing, with an expected peak in the next 10-20 years. Pleural malignant mesothelioma is the most common form of mesothelioma. T …
The exact prevalence is unknown but it is estimated that mesotheliomas represent less than 1% of all cancers. Its incidence is increa …
GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
Berg KB, Churg A. Berg KB, et al. Am J Surg Pathol. 2017 Sep;41(9):1221-1225. doi: 10.1097/PAS.0000000000000825. Am J Surg Pathol. 2017. PMID: 28614203
There was no correlation between the intensity and diffuseness of GATA-3 staining and staining for traditional mesothelioma markers. Overall, any positive staining for GATA3 was 100% sensitive and 85% specific for sarcomatoid/desmoplastic mesothelioma. We conclude t …
There was no correlation between the intensity and diffuseness of GATA-3 staining and staining for traditional mesothelioma markers. …
Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma.
Chiu K, Lee L, Cheung S, Churg AM. Chiu K, et al. Mod Pathol. 2018 Sep;31(9):1400-1403. doi: 10.1038/s41379-018-0066-y. Epub 2018 May 21. Mod Pathol. 2018. PMID: 29785020 Free article.
The aim of this study is to evaluate IHC glypican-1, a recently proposed marker for epithelioid mesothelioma, in our cohort of mesotheliomas and pulmonary adenocarcinoma. Tissue microarrays with duplicate cores from 33 cases of mesotheliomas (28 epithelioid t …
The aim of this study is to evaluate IHC glypican-1, a recently proposed marker for epithelioid mesothelioma, in our cohort of mes
18,899 results
Jump to page
Feedback